What is the optimal dosage of mesalazine to maintain remission in patients with ulcerative colitis?

被引：0
|
作者：
Simon Travis
机构：
[1] Consultant Gastroenterologist and Clinical Director of the Gastroenterology Unit,
[2] John Radcliffe Hospital,undefined
来源：
Nature Clinical Practice Gastroenterology & Hepatology | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：564 / 565
页数：1
相关论文
共 50 条
  • [41] Systematic review: safety of mesalazine in ulcerative colitis
    Sehgal, P.
    Colombel, J. -F.
    Aboubakr, A.
    Narula, N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (12) : 1597 - 1609
  • [42] The risks and the benefits of mesalazine as a treatment for ulcerative colitis
    Moss, Alan C.
    Peppercorn, Mark A.
    EXPERT OPINION ON DRUG SAFETY, 2007, 6 (02) : 99 - 107
  • [43] Mesalazine for ulcerative colitis complicated with diabetic nephropathy
    Hirokazu Oshimoto
    Shinichi Okamura
    Yasuhiro Onozato
    Hiroshi Ishihara
    Masatomo Mori
    Journal of Gastroenterology, 2001, 36 : 863 - 864
  • [44] Mesalazine for ulcerative colitis complicated with diabetic nephropathy
    Oshimoto, H
    Okamura, S
    Onozato, Y
    Ishihara, H
    Mori, M
    JOURNAL OF GASTROENTEROLOGY, 2001, 36 (12) : 863 - 864
  • [45] Myopericarditis in a patient with ulcerative colitis treated with mesalazine
    Martin, Maria
    Santamarta, Elena
    de la Iglesia, Jesus M.
    Saiz, Antonio
    MEDICINA CLINICA, 2010, 134 (01): : 43 - +
  • [46] A Mayo endoscopic sub-score of zero predicts long-term remission in patients with ulcerative colitis treated with mesalazine
    Sakemi, R.
    Tanaka, H.
    Miyakawa, M.
    Nasuno, M.
    Motoya, S.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S414 - S414
  • [47] MESALAZINE INDUCED EXACERBATION OF ULCERATIVE-COLITIS
    KAPUR, KC
    WILLIAMS, GT
    ALLISON, MC
    GUT, 1995, 37 (06) : 838 - 839
  • [48] Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission
    Ewe, K
    Becker, K
    Ueberschaer, B
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (04): : 225 - 229
  • [49] Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
    Kruis, W
    Schutz, E
    Fric, P
    Fixa, B
    Judmaier, G
    Stolte, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (05) : 853 - 858
  • [50] Randomised clinical trial of plantago ovata efficacy as compared to mesalazine in maintaining remission in ulcerative colitis.
    FernandezBanares, F
    Hinojosa, J
    SanchezLombrana, JL
    Salmeron, JFM
    GarciaPuges, A
    GonzalezHuix, F
    Riera, J
    Lara, VG
    DominguezAbascal, F
    Gine, JJ
    Moles, J
    Gomollon, F
    Gassull, MA
    GASTROENTEROLOGY, 1997, 112 (04) : A971 - A971
12345